BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND STIL, SIL, 6491, ENSG00000123473, Q15468
49 results:

  • 1. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Regulated by H3K36me3.
    Yin J; Qi TF; Li L; Wang Y
    Anal Chem; 2023 Jun; 95(25):9672-9679. PubMed ID: 37296074
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma.
    Haanen JBAG; Larkin J; Choueiri TK; Albiges L; Rini BI; Atkins MB; Schmidinger M; Penkov K; Michelon E; Wang J; Mariani M; di Pietro A; Motzer RJ
    ESMO Open; 2023 Jun; 8(3):101210. PubMed ID: 37104931
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis.
    Chen X; Li Y; Ding X; Zou J; Shen B; Liu Z; Lv W; Cao X; Xiang F
    Ren Fail; 2020 Nov; 42(1):419-427. PubMed ID: 32401100
    [No Abstract]    [Full Text] [Related]  

  • 4. Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.
    XiaoHong C; Bo S; FangFang X; Man G; JianZhou Z; ZhongHua L; WenLv L; XueSen C; XiaoQiang D; Boheng Z
    Int J Clin Oncol; 2019 Sep; 24(9):1151-1160. PubMed ID: 31183777
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Spontaneous Tumor Lysis Syndrome in a Patient with Testicular Malignant Lymphoma : A Case Report].
    Ichikawa K; Momose H; Mizobuchi SI; Itami Y; Nakahama T; Matsumoto Y; Nakamura T
    Hinyokika Kiyo; 2019 Feb; 65(2):49-53. PubMed ID: 31067843
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience.
    Lorenz F; Klimkowska M; Pawłowicz E; Bulanda Brustad A; Erlanson M; Machaczka M
    Leuk Lymphoma; 2018 Aug; 59(8):1840-1850. PubMed ID: 29295642
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.
    Nukui A; Masuda A; Abe H; Arai K; Yoshida KI; Kamai T
    BMC Cancer; 2017 May; 17(1):372. PubMed ID: 28545581
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. IL-15/sil-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
    Sun H; Liu D
    Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Digital image analysis of AgNORs in cervical smears of women with premalignant and malignant lesions of the uterine cervix.
    García-Vielma C; Dávila-Rodríguez MI; Hernández-Garza F; Cerda-Flores RM; Cortés-Gutiérrez EI
    Biotech Histochem; 2016; 91(2):102-7. PubMed ID: 26528580
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Interleukin-6 as an emerging regulator of renal cell cancer.
    Kamińska K; Czarnecka AM; Escudier B; Lian F; Szczylik C
    Urol Oncol; 2015 Nov; 33(11):476-85. PubMed ID: 26296264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
    Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
    Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
    Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
    Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
    Kado H; Hatta T; Ueno R; Takagi A; Segawa H; Sawada K; Hosokawa Y
    Nihon Jinzo Gakkai Shi; 2011; 53(7):1046-52. PubMed ID: 22073871
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
    Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
    Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. AgNOR polymorphism association with squamous intraepithelial lesions and invasive carcinoma with HPV infection.
    Alarcón-Romero Ldel C; Illades-Aguiar B; Flores-Alfaro E; Terán-Porcayo MA; Antonio-Véjar V; Reyes-Maldonado E
    Salud Publica Mex; 2009; 51(2):134-40. PubMed ID: 19377740
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients.
    Paternoster DM; Cester M; Resente C; Pascoli I; Nanhorngue K; Marchini F; Boccagni P; Cillo U; Ribaldone R; Amoruso E; Cocca N; Cuccolo V; Bertolino M; Surico N; Stratta P
    Transplant Proc; 2008; 40(6):1877-80. PubMed ID: 18675077
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
    Bien E; Balcerska A
    Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Serum level of soluble interleukin-2 receptor alpha correlates with the clinical course and activity of Wilms' tumour and soft tissue sarcomas in children.
    Bien E; Balcerska A; Kuchta G
    Biomarkers; 2007; 12(2):203-13. PubMed ID: 17536769
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Usefulness of serum markers in renal cell carcinoma].
    Rubio Briones J; Iborra Juan I; Aznar E; Climent MA; López-Guerrero JA; Maíquez J; Monrós Lliso JL; Casanova Ramón-Borja J; Dumont Martínez R; Ricós Torrent JV; Solsona Narbón E
    Actas Urol Esp; 2004 May; 28(5):381-6. PubMed ID: 15264681
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
    Böhm M; Ittenson A; Klatte T; Schierbaum KF; Röhl FW; Ansorge S; Allhoff EP
    Folia Biol (Praha); 2003; 49(2):63-8. PubMed ID: 12779014
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.